AHD-22407-40896
3 vaccinations
3 coded responses
24 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 970 / OR
- Registered
- 2020-12-29
- Relationship
- Self
- Race
- White
- Ethnicity
- N/A
Timeline
-
2020-12-29
Registered in v-safe
-
2020-12-29
Dose 1 — Pfizer-BioNTech
- 2020-12-29
-
2020-12-30
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2020-12-30
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2020-12-31
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-06
- 2021-01-13
-
2021-01-18
Dose 2 — Pfizer-BioNTech
-
2021-01-19
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness, Immediate post-injection reaction, Nausea — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Immediately after the shot, I got light headed, heart rate in the 130s. Was monitored at the clinic for 40 min. Went home and felt light headed and nauseated for about 2 hrs. Then it resolved.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-21
- 2021-01-22
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-02-01
- 2021-02-09
- 2021-02-15
- 2021-02-23
- 2021-03-03
-
2021-04-19
Survey response — 3 months, dose 2MedDRA: Hyperthyroidism — Feeling: GoodFree text: HyperthyroidismMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-19
-
2021-11-03
Dose 3 — Pfizer-BioNTech
-
2022-01-18
Survey response — 12 months, dose 2MedDRA: Dizziness, Dysstasia, Emergency care, Immediate post-injection reaction, Loss of consciousness, Nausea, Tachycardia, Tremor — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitFree text: After booster dose of Pfizer on 11/3/21 I had an immediate bad reaction causing me to need emergency care. Unable to stand without passing out, tachycardia, nausea, dizziness, shaking. Lasted 6 hrs. Residual issues lasted a few weeks.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-18
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
- 2022-01-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Pfizer-BioNTech | |
| 2 | 2021-01-18 | Pfizer-BioNTech | |
| 3 | 2021-11-03 | Pfizer-BioNTech | No |
Call center
2 call center cases
1 unsuccessful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Immediately after the shot, I got light headed, heart rate in the 130s. Was monitored at the clinic for 40 min. Went home and felt light headed and nauseated for about 2 hrs. Then it resolved.
Release 7 — 3 months, dose 2
Symptoms: Hyperthyroidism
Release 10 — 12 months, dose 2
Symptoms: After booster dose of Pfizer on 11/3/21 I had an immediate bad reaction causing me to need emergency care. Unable to stand without passing out, tachycardia, nausea, dizziness, shaking. Lasted 6 hrs. Residual issues lasted a few weeks.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dizziness | · | · | ✓ |
| SD | Dysstasia | · | · | ✓ |
| SD | Emergency care | · | · | ✓ |
| SD | Hyperthyroidism | ✓ | ✓ | ✓ |
| SD | Immediate post-injection reaction | · | · | ✓ |
| SD | Loss of consciousness | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Tachycardia | · | · | ✓ |
| SD | Tremor | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Immediate post-injection reaction | ✓ | ✓ | ✓ |
| SRO | Nausea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release